CDA FOUNDATION’S MISSION CDA Foundation seeks to eliminate Hepatitis B and C globally by 2030 through verified epidemiological data, disease burden and economic impact modeling, intervention strategies, access to affordable diagnostics and treatments, innovative financing models, and knowledge-sharing partnerships. We provide countries across the world with verified epidemiological data, disease burden and economic impact modeling, smart intervention strategies, access to affordable diagnostics and treatments, innovative financing and knowledge-sharing partnerships to eliminate this deadly disease. WHO WE ARE CDA Foundation (CDAF) is a non-profit organization that specializes in the study of complex and poorly-understood diseases in order to provide countries with the data and information to create and implement successful elimination strategies. Our team of epidemiologists has analyzed the impact of HBV and HCV in over 100 countries. We actively collaborate with more than 650 country experts—including NGOs, economists, Ministries of Health and Finance and key opinion leaders—to develop national strategies for Hepatitis elimination. We are highly collaborative, fully transparent and have over 65 peer-reviewed journal articles on hepatitis epidemiology and economic impact in publications such as The Lancet, the Journal of Viral Hepatitis, and the Journal of Medical Economics.